Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Trinity Biotech PLC (TRIB) had Debt to Capital Ratio of 1.70 for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$7.57M |
|
$-8.80M |
|
$5.66M |
|
$1.91M |
|
$14.05M |
|
$-6.48M |
|
$-2.31M |
|
$-8.79M |
|
$-8.79M |
|
$-8.80M |
|
$-8.80M |
|
$-8.80M |
|
$-8.80M |
|
$-6.48M |
|
$-5.84M |
|
18.30M |
|
18.30M |
|
$-0.48 |
|
$-0.48 |
|
| Balance Sheet Financials | |
$35.52M |
|
$4.38M |
|
$64.27M |
|
$99.79M |
|
$30.47M |
|
$105.53M |
|
$112.95M |
|
$143.41M |
|
$-43.62M |
|
$-97.28M |
|
$-43.62M |
|
-- |
|
| Cash Flow Statement Financials | |
$-2.88M |
|
$-1.98M |
|
$3.74M |
|
$5.17M |
|
$4.07M |
|
$-1.10M |
|
$0.13M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.17 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
1.70 |
-2.48 |
|
25.20% |
|
-85.64% |
|
-85.64% |
|
-- |
|
-116.13% |
|
-116.21% |
|
$-2.94M |
|
-- |
|
-- |
|
-- |
|
0.08 |
|
0.28 |
|
0.71 |
|
126.19 |
|
20.16% |
|
9.04% |
|
-8.82% |
|
-14.21% |
|
-- |
|
$-0.16 |
|
$-0.16 |
|